Amylyx Pharmaceuticals Ownership
| AMLX Etf | USD 5.66 0.39 7.40% |
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.
Amylyx |
Amylyx Etf Ownership Analysis
Amylyx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, engages in developing various therapeutics for amyotrophic lateral sclerosis and other neurodegenerative diseases. Amylyx Pharmaceuticals is listed under Biotechnology in the United States and is traded on NASDAQ Exchange exchange. For more info on Amylyx Pharmaceuticals please contact Justin Klee at 617 682 0917 or go to https://amylyx.com.Sector Exposure (%)
Investors will always prefer to have their portfolios divercified against different sectors. The broad sector allocation increases the possibility of making a profit or at least avoiding a loss. However, this may also reduce the expected return on Amylyx Etf. Generally, it depends on diversification level and type but usually, the broader the sector allocation, the less risk can be expected from holding Amylyx Pharmaceuticals , and the less return is expected.
Amylyx Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Amylyx Pharmaceuticals is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Amylyx Pharmaceuticals backward and forwards among themselves. Amylyx Pharmaceuticals' institutional investor refers to the entity that pools money to purchase Amylyx Pharmaceuticals' securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Morgan Stanley - Brokerage Accounts | 2024-06-30 | 1.8 M | Millennium Management Llc | 2024-06-30 | 1.5 M | Nantahala Capital Management, Llc | 2024-09-30 | 1.4 M | Two Sigma Advisers, Llc | 2024-06-30 | 1.2 M | Farallon Capital Management, L.l.c. | 2024-09-30 | 1.2 M | Qube Research & Technologies | 2024-06-30 | 789.1 K | D. E. Shaw & Co Lp | 2024-09-30 | 691.1 K | Alpha Wave Global Lp | 2024-09-30 | 669.5 K | Connor Clark & Lunn Inv Mgmt Ltd | 2024-06-30 | 621.9 K | Tcg Crossover Management, Llc | 2024-09-30 | 4.6 M | Aqr Capital Management Llc | 2024-06-30 | 3.3 M |
Top Etf Constituents
| WES | Western Midstream Partners | Stock | |
| VNOM | Viper Energy Ut | Stock | |
| GEL | Genesis Energy LP | Stock | |
| NGL | NGL Energy Partners | Stock | |
| PAGP | Plains GP Holdings | Stock | |
| MPLX | MPLX LP | Stock | |
| NS | NuStar Energy LP | Stock | |
| CQP | Cheniere Energy Partners | Stock | |
| DCP | DCP Midstream LP | Stock | |
| HEP | Holly Energy Partners | Stock | |
| CEQP | Crestwood Equity Partners | Stock |
Amylyx Pharmaceuticals Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Amylyx Pharmaceuticals insiders, such as employees or executives, is commonly permitted as long as it does not rely on Amylyx Pharmaceuticals' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Amylyx Pharmaceuticals insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Amylyx Pharmaceuticals Outstanding Bonds
Amylyx Pharmaceuticals issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Amylyx Pharmaceuticals uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Amylyx bonds can be classified according to their maturity, which is the date when Amylyx Pharmaceuticals has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| AMSOUTH BANCORPORATION 675 Corp BondUS032165AD41 | View | |
| Amsted Industries 5625 Corp BondUS032177AH01 | View | |
| Amsted Industries 4625 Corp BondUS032177AJ66 | View | |
| SILAMX 5375 04 APR 32 Corp BondUS03217KAB44 | View |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Amylyx Etf
Amylyx Pharmaceuticals financial ratios help investors to determine whether Amylyx Etf is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Amylyx with respect to the benefits of owning Amylyx Pharmaceuticals security.